Vilenchik; Maria

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vilenchik; Maria.The latest application filed is for "combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis".

Company Profile

7.5.8

Vilenchik; Maria - Newton MA
Vilenchik; Maria - Natick MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combinations For The Treatment Of Neoplasms Using Quiescent Cell Targeting And Inhibitors Of Mitosis App 20220110941 - Vilenchik; Maria ; et al.	2022-04-14
Combinations For The Treatment Of Neoplasms Using Quiescent Cell Targeting With Egfr Inhibitors App 20220110940 - Vilenchik; Maria ; et al.	2022-04-14
Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors Grant 11,202,779 - Vilenchik , et al. December 21, 2	2021-12-21
Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases Grant 10,577,365 - Dreas , et al.	2020-03-03
Combinations For The Treatment Of Neoplasms Using Quiescent Cell Targeting With Egfr Inhibitors App 20190298723 - Vilenchik; Maria ; et al.	2019-10-03
Combinations For The Treatment Of Neoplasms Using Quiescent Cell Targeting And Inhibitors Of Mitosis App 20190290651 - Vilenchik; Maria ; et al.	2019-09-26
Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors Grant 10,322,128 - Vilenchik , et al.	2019-06-18
Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis Grant 10,314,843 - Vilenchik , et al.	2019-06-11
Derivatives Of Quinoline As Inhibitors Of Dyrk1a And/or Dyrk1b Kinases App 20180179199 - Dreas; Agnieszka ; et al.	2018-06-28
Combinations For The Treatment Of Neoplasms Using Quiescent Cell Targeting With Egfr Inhibitors App 20170296541 - Vilenchik; Maria ; et al.	2017-10-19
Combinations For The Treatment Of Neoplasms Using Quiescent Cell Targeting And Inhibitors Of Mitosis App 20170296542 - Vilenchik; Maria ; et al.	2017-10-19
Treatment Of Cancer By Targeting Quiescent Cancer Cells App 20150292032 - Vilenchik; Maria ; et al.	2015-10-15
Substrate useful for separating modified oligonucleotides Grant 5,643,717 - Cohen , et al. * July 1, 1	1997-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.